Keith Stockerl-Goldstein is an Oncology physician. OpenAlex indexes 407 publications with 14,467 citations (h-index 55); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4500 Forest Park Ave
Div Im Bone Marrow Transplant, 5th, 6th, 8th Fl
Saint Louis, MO 631082114
Telephone
314-454-8304Registry record last updated 17 Apr 2025.
Clinical trials
3 registered studies on ClinicalTrials.gov matched to this name. Itemized trial rows, roles and sponsors are part of the full profile. Why? →
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Scientific Affairs, LLCProgram year20251 payment
- GENZYME CORPORATIONProgram year20241 payment
- Janssen Scientific Affairs, LLCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
87.3%CD38-directed Cytolytic Antibody84%Daratumumab100%Part B, office-administered≥23 patientsThalidomide Analog3.1%Revlimid57%Lenalidomide30%Pomalyst13%Part D≥46 patients+ 2 more classes in this area
Nervous system
3.9%Opioid Agonist2%Oxycodone Hcl41%Morphine Sulfate Er31%Tramadol Hcl12%Oxycontin8%Oxycodone-Acetaminophen5%Morphine Sulfate3%Part D<11 patientsGabapentinoids0.7%Gabapentin69%Pregabalin32%Part D<11 patients+ 5 more classes in this area
Sensory organs
2.3%Corticosteroid2.3%Dexamethasone sodium phosphate80%Dexamethasone20%Part D + Part B≥32 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”